Transparency Market Research Immunoprotein Diagnostic Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
Published Date 2014-04-24
96 Page Report
Buy Now
Request Sample
Press Release
Immunoprotein Diagnostic Testing Market Driven by Urgent Need for Preventive Healthcare in Emerging Economies Transparency Market Research State Tower, 90, State Street, Suite 700. Albany, NY 12207 United States www.transparencymarketresearch.com sales@transparencymarketresearch.com
Immunoprotein Diagnostic Testing Market
REPORT DESCRIPTION
Immunoprotein Diagnostic Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019 Increased research and development efforts have greatly contributed to the growth of the immunoprotein diagnostic testing market in recent years, states a recent report published by Transparency Market Research. The report, titled “ Immunoprotein Diagnostic Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 �, indicates that, registering a CAGR of 5.7% from 2013 and 2019, the global immunoprotein diagnostic testing market stands to expand from US$11,019.7 million in 2012 to US$15,351.0 million in 2019. The research report segments the global immunoprotein diagnostic testing market on the basis of assay technology, immunoprotein type, application, and geography. By the type of immunoprotein tested, the market is categorized into C-reactive protein diagnostic tests, free light chain diagnostic tests, prealbumin diagnostic tests, complement system protein diagnostic tests, immunoglobulin diagnostic tests, and haptoglobin diagnostic tests. The C-reactive protein diagnostic test has been the largest segment owing to its effective and accurate diagnosis of injuries, inflammation-related disorders, strokes, and cardiovascular diseases. However, analysts believe that, being in the initial stages of development, the segment of free light chain diagnostic tests is likely to pick up pace in the near future. Browse the full Immunoprotein Diagnostic Testing Market Report @ :http://www.transparencymarketresearch.com/immunoprotein-diagnostictesting.html On the basis of technology, the market for immunoprotein diagnostic testing is segmented into enzyme-based immunoassay, radioimmunoassay, chemiluminescence assay, immunofluorescence assay, immunoprotein electrophoresis, and immunoturbidity assay. The chemiluminecence assay segment dominated the global immunoprotein diagnostic testing market in 2012, due to its feasibility for wide-scale application, sensitivity, safety, and ease of use. The segment of radioimmunoassay testing has been losing market share over the years owing to high cost of equipment and devices, strict healthcare regulations, and high exposure to radiation. Doctors and clinicians have switched to safer and more effective tests, leading to a decline in the radioimmunoassay testing market.
Transparency Market Research
2
Immunoprotein Diagnostic Testing Market
Browse the full Immunoprotein Diagnostic Testing Market Press Release @ :http://www.transparencymarketresearch.com/pressrelease/immunoproteindiagnostic-testing.htm Immunoprotein diagnostic testing finds application in endocrine testing, allergy testing, infectious diseases, toxicology testing, oncology testing, and autoimmune disease testing. The report indicates that the segment of oncology testing will generate maximum revenue by the end of the forecast period, presenting a market worth of US$4,943.0 million in 2019 and growing at a CAGR of 6% from 2013 to 2019.The report identifies some of the major factors governing the growth of the immunoprotein diagnostic testing market. According to the report, the growing demand for quick, accurate, and preventive healthcare – especially in emerging economies – is a primary factor boosting the global market. In addition, technological development, commoditization of products, expansion in the field of immunochromatography, and strengthening network of distributors at a global level has also contributed to the growth of the immunoprotein diagnostic testing market. In contrast, high cost of diagnosis is likely to restrict the development of this market over the forecast period. Some of the leading players in the global immunoprotein diagnostic testing market are DiaSorin SPA, Thermo Fisher Scientific, Inc., The Binding Site Group Ltd., Abcam PLC, Omega Diagnostics Group PLC, Randox Laboratories Ltd., Siemens AG, Enzo Life Sciences, Inc., Roche Holding AG, Fujirebio Diagnostics, Inc., and Abbott Laboratories, Inc. These players are profiled on the basis of parameters such as company and financial overview, recent developments, product portfolio, business strategies, and a SWOT analysis. Get Free Sample Report : http://www.transparencymarketresearch.com/sample/sample.php? flag=s&rep_id=1253 TABLE OF CONTENT
Table of Content
Chapter 1 Introduction
Transparency Market Research
3
Immunoprotein Diagnostic Testing Market
1.1 Report Description 1.2 Market Segmentation 1.3 Research Methodology 1.3.1 Secondary Research 1.3.2 Primary Research 1.4 List of Abbreviations 1.5 Assumptions and Stipulations
Chapter 2 Executive Summary
Chapter 3 Global Immunoprotein Diagnostic Testing Market Overview 3.1 Introduction 3.2 Market Trends and Future Outlook 3.3 Market Dynamics 3.3.1 Drivers 3.3.1.1 Rising need for quick and accurate disease diagnosis 3.3.1.2 Technological advancement 3.3.1.3 Rising demand for preventive healthcare in developing economies 3.3.1.4 Strong network of distributors across the globe 3.3.1.5 Commoditization of products
Transparency Market Research
4
Immunoprotein Diagnostic Testing Market
3.3.2 Restraints 3.3.2.1 Higher cost of diagnosis 3.3.2.2 Installed base of traditional ELISA 3.3.3 Opportunities 3.3.3.1 Immunochromatography 3.3.3.2 Research and development 3.3.3.3 Expansion in emerging economies 3.1 Porter’s Five Force Analysis for the Global Immunoprotein Diagnostic Testing Market 3.1.1 Bargaining Power of Suppliers 3.1.2 Bargaining Power of Buyers 3.1.3 Threat of Substitutes 3.1.4 Threat of New Entrants 3.1.5 Competitive Rivalry 3.2 Market Attractiveness Analysis for the Global Immunoprotein Diagnostic Testing Market, by Geography 3.3 Heat Map Analysis: Global Immunoprotein Diagnostic Testing Market 3.3.1 Methodology 3.3.2 Heat Map Analysis for the Global Immunoprotein Diagnostic Testing Market, by key players, 2012
Transparency Market Research
5
Immunoprotein Diagnostic Testing Market
Chapter 4 Global Immunoprotein Diagnostic Testing Market, by Assay Technology 4.1 Introduction 4.1.1 Global Immunoprotein Diagnostic Testing Market Revenue, by Assay Technology, 2011 - 2019 (USD Million) 4.2 Radioimmunoassay 4.2.1 Global Radioimmunoassay Market Revenue, 2011 - 2019 (USD Million) 4.3 Enzyme Based Immunoassay 4.3.1 Global Enzyme Based Immunoassay Market Revenue, 2011 - 2019 (USD Million) 4.4 Chemiluminescence Assay 4.4.1 Global Chemiluminescence Assay Market Revenue, 2011 - 2019 (USD Million) 4.5 Immunofluorescence Assay 4.5.1 Global Immunofluorescence Assay Market Revenue, 2011 - 2019 (USD Million) 4.6 Immunoturbidity Assay 4.6.1 Global Immunoturbidity Assay Market Revenue, 2011 - 2019 (USD Million) 4.7 Immunoprotein Electrophoresis 4.7.1 Global Immunoprotein Electrophoresis Assay Market Revenue, 2011 - 2019 (USD Million)
Chapter 5 Global Immunoprotein Diagnostic Testing Market, by Immunoprotein Type 5.1 Introduction
Transparency Market Research
6
Immunoprotein Diagnostic Testing Market
5.1.1 Global Immunoprotein Diagnostic Testing Market Revenue, by Immunoprotein Type, 2011 - 2019 (USD Million) 5.2 Complement System Proteins Diagnostic Tests 5.2.1 Global Complement System Protein Diagnostic Tests Market Revenue, 2011 - 2019 (USD Million) 5.3 Free Light Chain Diagnostic Tests 5.3.1 Global Free Light Chain Diagnostic Tests Market Revenue, 2011 - 2019 (USD Million) 5.4 Haptoglobin Diagnostic Tests 5.4.1 Global Haptoglobin Diagnostic Tests Market Revenue, 2011 - 2019 (USD Million) 5.5 Immunoglobulin Diagnostic Tests 5.5.1 Global Immunoglobulin Diagnostic Tests Market Revenue, 2011 - 2019 (USD Million) 5.6 Prealbumin Diagnostic Tests 5.6.1 Global Prealbumin Diagnostic Tests Market Revenue, 2011 - 2019 (USD Million) 5.7 C-Reactive Protein (CRP) Diagnostic Tests 5.7.1 Global C-Reactive Protein Diagnostic Tests Market Revenue, 2011 - 2019 (USD Million)
Chapter 6 Global Immunoprotein Diagnostic Testing Market, by Application 6.1 Introduction 6.1.1 Global Immunoprotein Diagnostic Testing Market Revenue, by Application, 2011 2019 (USD Million) 6.2 Infectious Disease Testing
Transparency Market Research
7
Immunoprotein Diagnostic Testing Market
6.2.1 Global Infectious Disease Testing Market Revenue, 2011 - 2019 (USD Million) 6.3 Oncology Testing 6.3.1 Global Oncology Testing Market Revenue, 2011 - 2019 (USD Million) 6.4 Endocrine Testing 6.4.1 Global Endocrine Testing Market Revenue, 2011 - 2019 (USD Million) 6.5 Toxicology Testing 6.5.1 Global Toxicology Testing Market Revenue, 2011 - 2019 (USD Million) 6.6 Allergy Testing 6.6.1 Global Allergy Testing Market Revenue, 2011 - 2019 (USD Million) 6.7 Autoimmune Disease Testing 6.7.1 Global Autoimmune Disease Testing Market Revenue, 2011 - 2019 (USD Million)
Chapter 7 Global Immunoprotein Diagnostic Testing Market, by Geography 7.1 Introduction 7.1.1 Global Immunoprotein Diagnostic Testing Market Revenue, by Geography, 2011 – 2019 (USD Million) 7.2 North America 7.2.1 North America Immunoprotein Diagnostic Testing Market Revenue, by Assay Technology, 2011 – 2019 (USD Million) 7.3 Europe
Transparency Market Research
8
Immunoprotein Diagnostic Testing Market
7.3.1 Europe Immunoprotein Diagnostic Testing Market Revenue, by Assay Technology, 2011 – 2019 (USD Million) 7.4 Asia-Pacific 7.4.1 Asia-Pacific Immunoprotein Diagnostic Testing Market Revenue, by Assay Technology, 2011 – 2019 (USD Million) 7.5 Rest of the World (RoW) 7.5.1 Rest of the World Immunoprotein Diagnostic Testing Market Revenue, by Assay Technology, 2011 – 2019 (USD Million)
Chapter 8 Recommendations 8.1 Untapped allergy testing market 8.2 Future of oncology testing 8.3 Upgrading to latest technology
Chapter 9 Company Profiles 9.1 Abbott Laboratories, Inc. 9.1.1 Company Overview 9.1.2 Financial Overview 9.1.3 Product Portfolio 9.1.4 Business Strategies 9.1.5 Recent Developments
Transparency Market Research
9
Immunoprotein Diagnostic Testing Market
9.2 Abcam PLC 9.2.1 Company Overview 9.2.2 Financial Overview 9.2.3 Product Portfolio 9.2.4 Business Strategies 9.2.5 Recent Developments 9.3 DiaSorin SPA 9.3.1 Company Overview 9.3.2 Financial Overview 9.3.3 Product Portfolio 9.3.4 Business Strategies 9.3.5 Recent Developments 9.4 Enzo Life Sciences, Inc. 9.4.1 Company Overview 9.4.2 Financial Overview 9.4.3 Product Portfolio 9.4.4 Business Strategies 9.4.5 Recent Developments 9.5 Fujirebio Diagnostics, Inc. 9.5.1 Company Overview
Transparency Market Research
10
Immunoprotein Diagnostic Testing Market
9.5.2 Financial Overview 9.5.3 Product Portfolio 9.5.4 Business Strategies 9.5.5 Recent Developments 9.6 Omega Diagnostics Group PLC 9.6.1 Company Overview 9.6.2 Financial Overview 9.6.3 Product Portfolio 9.6.4 Business Strategies 9.6.5 Recent Developments 9.7 Randox Laboratories Ltd. 9.7.1 Company Overview 9.7.2 Financial Overview 9.7.3 Product Portfolio 9.7.4 Business Strategies 9.7.5 Recent Developments 9.8 Roche Holding AG 9.8.1 Company Overview 9.8.2 Financial Overview 9.8.3 Product Portfolio
Transparency Market Research
11
Immunoprotein Diagnostic Testing Market
9.8.4 Business Strategies 9.8.5 Recent Developments 9.9 Siemens AG 9.9.1 Company Overview 9.9.2 Financial Overview 9.9.3 Product Portfolio 9.9.4 Business Strategies 9.9.5 Recent Developments 9.10 The Binding Site Group Ltd. 9.10.1 Company Overview 9.10.2 Financial Overview 9.10.3 Product Portfolio 9.10.4 Business Strategies 9.10.5 Recent Developments 9.11 Thermo Fisher Scientific, Inc. 9.11.1 Company Overview 9.11.2 Financial Overview 9.11.3 Product Portfolio 9.11.4 Business Strategies 9.11.5 Recent Developments
Transparency Market Research
12
Immunoprotein Diagnostic Testing Market
List of Figures
FIG. 1 Global Immunoprotein Diagnostic Testing Market – Market Segmentation FIG. 2 Global Immunoprotein Diagnostic Testing Market Revenue, 2011-2019 (USD Million) FIG. 3 Porter’s Five Force Analysis: Global Immunoprotein Diagnostic Testing Market FIG. 4 Market Attractiveness Analysis: Global Immunoprotein Diagnostic Testing Market, by Geography FIG. 5 Heat Map Analysis: Global Immunoprotein Diagnostic Testing Market, by Key Players (2012) FIG. 6 Global Radioimmunoassay Market Revenue, 2011 - 2019 (USD Million) FIG. 7 Global Enzyme Based Immunoassay Market Revenue, 2011 – 2019 (USD Million) FIG. 8 Global Chemiluminescence Assay Market Revenue, 2011 – 2019 (USD Million) FIG. 9 Global Immunofluorescence Assay Market Revenue, 2011 – 2019 (USD Million) FIG. 10 Global Immunoturbidity Assay Market Revenue, 2011 – 2019 (USD Million) FIG. 11 Global Immunoprotein Electrophoresis Assay Market Revenue, 2011 – 2019 (USD Million) FIG. 12 Global Complement System Protein Diagnostic Tests Market Revenue, 2011 - 2019 (USD Million) FIG. 13 Global Free Light Chain Diagnostic Tests Market Revenue, 2011 - 2019 (USD Million) FIG. 14 Global Haptoglobin Diagnostic Tests Market Revenue, 2011 - 2019 (USD Million) FIG. 15 Global Immunoglobulin Diagnostic Tests Market Revenue, 2011 - 2019 (USD Million)
Transparency Market Research
13
Immunoprotein Diagnostic Testing Market
FIG. 16 Global Prealbumin Dagnostic Tests Market Revenue, 2011 - 2019 (USD Million) FIG. 17 Global C-Reactive Protein Diagnostic Tests Market Revenue, 2011 - 2019 (USD Million) FIG. 18 Global Infectious Disease Testing Market Revenue, 2011 - 2019 (USD Million) FIG. 19 Global Oncology Testing Market Revenue, 2011 - 2019 (USD Million) FIG. 20 Global Endocrine Testing Market Revenue, 2011 - 2019 (USD Million) FIG. 21 Global Toxicology Testing Market Revenue, 2011 - 2019 (USD Million) FIG. 22 Global Allergy Testing Market Revenue, 2011 - 2019 (USD Million) FIG. 23 Global Autoimmune Disease Testing Market Revenue, 2011 - 2019 (USD Million) FIG. 24 Abbott Laboratories, Inc.: Annual Revenue, 2010 – 2012 (USD Million) FIG. 25 Abcam PLC: Annual Revenue, 2010 – 2012 (USD Million) FIG. 26 DiaSorin SPA: Annual Revenue, 2010 – 2012 (USD Million) FIG. 27 Omega Diagnostics Group PLC: Annual Revenue, 2010 – 2012 (USD Million) FIG. 28 Roche Holding AG: Annual Revenue, 2010 – 2012 (USD Million) FIG. 29 Siemens AG (Healthcare Segment): Annual Revenue, 2010 – 2012 (USD Million) FIG. 30 Thermo Fisher Scientific, Inc.: Annual Revenue, 2010 – 2012 (USD Million) List of Tables
TABLE 1 Market Snapshot: Global Immunoprotein Diagnostic Testing Market TABLE 2 Global Immunoprotein Diagnostic Testing Market Revenue, by Assay Technology, 2011 - 2019 (USD Million)
Transparency Market Research
14
Immunoprotein Diagnostic Testing Market
TABLE 3 Global Immunoprotein Diagnostic Testing Market Revenue, by Immunoprotein Type, 2011 - 2019 (USD Million) TABLE 4 Global Immunoprotein Diagnostic Testing Market Revenue, by Application, 2011 - 2019 (USD Million) TABLE 5 Global Immunoprotein Diagnostic Testing Market Revenue, by Geography, 2011 – 2019 (USD Million) TABLE 6 North America Immunoprotein Diagnostic Testing Market Revenue, by Assay Technology, 2011 – 2019 (USD Million) TABLE 7 Europe Immunoprotein Diagnostic Testing Market Revenue, by Assay Technology, 2011 – 2019 (USD Million) TABLE 8 Asia-Pacific Immunoprotein Diagnostic Testing Market Revenue, by Assay Technology, 2011 – 2019 (USD Million) TABLE 9 Rest of the World Immunoprotein Diagnostic Testing Market Revenue, by Assay Technology, 2011 – 2019 (USD Million)
Browse All Biotechnology Market Research Reports @ http://www.transparencymarketresearch.com/biotechnology-market-reports-18.html About Us
Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forwardlooking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our
Transparency Market Research
15
Immunoprotein Diagnostic Testing Market
business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Contact Transparency Market Research 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com/
Transparency Market Research
16